Evidence map›Paper›PMID 32707266›Full record

ReviewAmerican journal of obstetrics and gynecology2020

Menstruation: science and society.

Hilary O D Critchley, Elnur Babayev, Serdar E Bulun, Sandy Clark, Iolanda Garcia-Grau, Peter K Gregersen, Aoife Kilcoyne, Ji-Yong Julie Kim, Missy Lavender, Erica E Marsh and 11 more

Open access · bronzeAbstract readReview
In one paragraph

Review in American journal of obstetrics and gynecology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 154 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
154citing papers in PubMed, 6 pooled it
36.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

154 citing papers in PubMed, 6 syntheses or guidelines pooled it, 417 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Trial
  8. Trial
  9. Trial
  10. Article
  11. Women living with diabetes: Overlooked and under-recognised, the psychosocial impact.Diabetic medicine : a journal of the British Diabetic Association · 2026
    Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review

94 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

21 authors at 15 institutions in 3 countries.

Hilary O D CritchleyMedical Research Council Centre for Reproductive Health, The University of Edinburgh, United Kingdom. Electronic address: hilary.critchley@ed.ac.uk.
Elnur BabayevDepartment of Obstetrics and Gynecology, Feinberg School of Medicine, Northwestern University, Chicago, IL.
Serdar E BulunDepartment of Obstetrics and Gynecology, Feinberg School of Medicine, Northwestern University, Chicago, IL.
Sandy ClarkDays for Girls, Mt. Vernon, WA.
Iolanda Garcia-GrauIgenomix Foundation-Instituto de Investigación Sanitaria Hospital Clínico, INCLIVA, Valencia, Spain; Department of Pediatrics, Obstetrics and Gynecology, School of Medicine, University of Valencia, Valencia, Spain.
Peter K GregersenThe Feinstein Institutes for Medical Research, Northwell Health, Manhasset, NY.
Aoife KilcoyneMassachusetts General Hospital, Boston, MA.
Ji-Yong Julie KimFeinberg School of Medicine, Northwestern University, Chicago, IL.
Missy LavenderBelow your Belt Health, Chicago, IL.
Erica E MarshDivision of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, University of Michigan Medical School, Ann Arbor, MI.
Kristen A MattesonDivision of Research, Department of Obstetrics and Gynecology, Women and Infants Hospital, Warren Alpert Medical School of Brown University, Providence, RI.
Jacqueline A MaybinMedical Research Council Centre for Reproductive Health, The University of Edinburgh, United Kingdom.
Christine N MetzThe Feinstein Institutes for Medical Research, Northwell Health, Manhasset, NY.
Inmaculada MorenoIgenomix Foundation-Instituto de Investigación Sanitaria Hospital Clínico, INCLIVA, Valencia, Spain.
Kami SilkDepartment of Communication, University of Delaware, Newark, DE.
Marni SommerDepartment of Sociomedical Sciences, Columbia University Mailman School of Public Health, New York, NY.
Carlos SimonIgenomix Foundation-Instituto de Investigación Sanitaria Hospital Clínico, INCLIVA, Valencia, Spain; Department of Pediatrics, Obstetrics and Gynecology, School of Medicine, University of Valencia, Valencia, Spain; Beth Israel Deaconess Medical Center, Harvard University, Boston, MA; Department of Obstetrics and Gynecology, Baylor College of Medicine, Houston, TX.
Ridhi TariyalNextGen Jane, Oakland, CA.
Hugh S TaylorDepartment of Obstetrics, Gynecology and Reproductive Sciences, Yale School of Medicine, New Haven, CT.
Günter P WagnerDepartment of Ecology and Evolutionary Biology, Department of Obstetrics, Gynecology and Reproductive Sciences, Systems Biology Institute, Yale University, New Haven, CT; Department of Obstetrics and Gynecology, Wayne State University, Detroit, MI.
Linda G GriffithCenter for Gynepathology Research, Massachusetts Institute of Technology, Cambridge, MA.
Northwestern University · USIgenomix · ESYale University · USBrown University · USColumbia University · USFeinstein Institute for Medical Research · USGirls Incorporated · USMassachusetts General Hospital · USMassachusetts Institute of Technology · USMedical Research Council · GBMRC Centre for Reproductive Health · GBNorthwell Health · USUniversitat de València · ESUniversity of Delaware · USUniversity of Michigan–Ann Arbor · US

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
Uterine Leiomyoma Research Center ProgramP01HD057877 · NICHD · NORTHWESTERN UNIVERSITY AT CHICAGO · PI BULUN, SERDAR E. · 2009 to 2019
$12.2M
Systems analysis of phenotypic switch in control of cancer invasionU54CA209992 · NCI · YALE UNIVERSITY · PI LEVCHENKO, ANDRE · 2016 to 2021
$10.1M
Endometriosis and RetinoidsR37HD038691 · NICHD · NORTHWESTERN UNIVERSITY AT CHICAGO · PI BULUN, SERDAR E. · 2010 to 2019
$4.5M
PCOS and androgen-related disease modeling and drug testing in Multi-organ Integrated Microfluidic Reproductive PlatformUH3ES029073 · NIEHS · NORTHWESTERN UNIVERSITY AT CHICAGO · PI KIM, JI-YONG JULIE · 2019 to 2021
$3.6M
PCOS and androgen-related disease modeling and drug testing in Multi-organ Integrated Microfluidic Reproductive PlatformUG3ES029073 · NIEHS · NORTHWESTERN UNIVERSITY AT CHICAGO · PI WOODRUFF, TERESA K · 2017 to 2018
$3.0M
Establishing a Long Island Bioscience HubU01HL127522 · NHLBI · STATE UNIVERSITY NEW YORK STONY BROOK · PI RUBIN, CLINTON T · 2015 to 2017
$3.0M
Microvascular Permeability, Inflammation, and Lesion Physiology in Endometriosis: A Microphysiological Systems ApproachU01EB029132 · NIBIB · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI GRIFFITH, LINDA G · 2019 to 2023
$2.9M
Understanding Progesterone Receptor action in Obesity for Endometrial Cancer PreventionR01CA243249 · NCI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI KIM, JI-YONG JULIE · 2019 to 2024
$2.6M
Medical Research Council G0500047Medical Research Council G0600048Medical Research Council MR/J003611/1NCATS NIH HHS UL1 TR001863NCI NIH HHS R01 CA243249NCI NIH HHS U54 CA209992NHLBI NIH HHS U01 HL127522NIBIB NIH HHS U01 EB029132NICHD NIH HHS P01 HD057877NICHD NIH HHS R37 HD038691NIEHS NIH HHS UG3 ES029073NIEHS NIH HHS UH3 ES029073Wellcome Trust 209589/Z/17/Z
6 · The paper itself

Abstract

Women's health concerns are generally underrepresented in basic and translational research, but reproductive health in particular has been hampered by a lack of understanding of basic uterine and menstrual physiology. Menstrual health is an integral part of overall health because between menarche and menopause, most women menstruate. Yet for tens of millions of women around the world, menstruation regularly and often catastrophically disrupts their physical, mental, and social well-being. Enhancing our understanding of the underlying phenomena involved in menstruation, abnormal uterine bleeding, and other menstruation-related disorders will move us closer to the goal of personalized care. Furthermore, a deeper mechanistic understanding of menstruation-a fast, scarless healing process in healthy individuals-will likely yield insights into a myriad of other diseases involving regulation of vascular function locally and systemically. We also recognize that many women now delay pregnancy and that there is an increasing desire for fertility and uterine preservation. In September 2018, the Gynecologic Health and Disease Branch of the Eunice Kennedy Shriver National Institute of Child Health and Human Development convened a 2-day meeting, "Menstruation: Science and Society" with an aim to "identify gaps and opportunities in menstruation science and to raise awareness of the need for more research in this field." Experts in fields ranging from the evolutionary role of menstruation to basic endometrial biology (including omic analysis of the endometrium, stem cells and tissue engineering of the endometrium, endometrial microbiome, and abnormal uterine bleeding and fibroids) and translational medicine (imaging and sampling modalities, patient-focused analysis of menstrual disorders including abnormal uterine bleeding, smart technologies or applications and mobile health platforms) to societal challenges in health literacy and dissemination frameworks across different economic and cultural landscapes shared current state-of-the-art and future vision, incorporating the patient voice at the launch of the meeting. Here, we provide an enhanced meeting report with extensive up-to-date (as of submission) context, capturing the spectrum from how the basic processes of menstruation commence in response to progesterone withdrawal, through the role of tissue-resident and circulating stem and progenitor cells in monthly regeneration-and current gaps in knowledge on how dysregulation leads to abnormal uterine bleeding and other menstruation-related disorders such as adenomyosis, endometriosis, and fibroids-to the clinical challenges in diagnostics, treatment, and patient and societal education. We conclude with an overview of how the global agenda concerning menstruation, and specifically menstrual health and hygiene, are gaining momentum, ranging from increasing investment in addressing menstruation-related barriers facing girls in schools in low- to middle-income countries to the more recent "menstrual equity" and "period poverty" movements spreading across high-income countries.

Indexed as

Global HealthHealth LiteracyMenstrual Hygiene ProductsMenstruationUterine HemorrhageWomen's HealthAdenomyosisAttitudeBiological EvolutionBiomedical ResearchCongresses as TopicDeveloping CountriesEducationEndometriosisEndometriumFemaleabnormal uterine bleedingadenomyosisendometriumfibroidsmenstrual healthmicrobiomepelvic health menstrual effluentperiod povertystem cellstissue engineeringuterus

Identifiers

PMID32707266
PMCPMC7661839
OpenAlexW3043929714

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.